首页> 外文期刊>FEBS letters. >MiR-155 targets TP53INP1 to regulate liver cancer stem cell acquisition and self-renewal
【24h】

MiR-155 targets TP53INP1 to regulate liver cancer stem cell acquisition and self-renewal

机译:MiR-155靶向TP53INP1来调节肝癌干细胞的获取和自我更新

获取原文
获取原文并翻译 | 示例
       

摘要

In liver cancer, miR-155up-regulation can regulate cancer-cell invasion. However, whether miR-155 expression is associated with liver cancer stem cells (CSCs) remains unknown. Here, we show that miR-155 expression is up-regulated in tumor spheres. Knock-down of miR-155 resulted in suppression of tumor sphere formation, through a decrease in the proportion of CD90(+) and CD133(+) CSCs and in the expression of Oct4, whereas miR-155 overexpression had the opposite effect. TP53INP1 was determined to be involved in the CSCs-like properties that were regulated by miR-155. Thus, miR-155 may play an important role in promoting the generation of stem cell-like cells and their selfrenewal by targeting the gene TP53INP1. (C) 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
机译:在肝癌中,miR-155上调可以调节癌细胞的侵袭。但是,miR-155表达是否与肝癌干细胞(CSCs)相关尚不清楚。在这里,我们显示miR-155表达在肿瘤领域中上调。通过减少CD90(+)和CD133(+)CSC的比例以及Oct4的表达,miR-155的抑制导致肿瘤球形成的抑制,而miR-155的过表达具有相反的作用。 TP53INP1被确定参与由miR-155调控的CSC样特性。因此,miR-155通过靶向基因TP53INP1在促进干细胞样细胞的产生及其自我更新中可能起重要作用。 (C)2015年欧洲生物化学学会联合会。由Elsevier B.V.发布。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号